These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16946747)

  • 1. Inadvertent injection of triamcinolone into the crystalline lens.
    Jalil A; Chaudhry NL; Gandhi JS; Odat TM; Yodaiken M
    Eye (Lond); 2007 Jan; 21(1):152-4. PubMed ID: 16946747
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inadvertent administration of intralenticular triamcinolone.
    Rajak SN; Dubois VD; Mokete B; Casswell AG
    Eye (Lond); 2007 Mar; 21(3):426-7. PubMed ID: 17187031
    [No Abstract]   [Full Text] [Related]  

  • 4. Ptosis following an intravitreal injection of triamcinolone acetonide.
    Viola F; Morescalchi F; Ratiglia R; Staurenghi G
    Eye (Lond); 2007 Mar; 21(3):421-3. PubMed ID: 16498434
    [No Abstract]   [Full Text] [Related]  

  • 5. The inadvertent administration of intralenticular triamcinolone.
    Kumar BV; Salvi SM; Prasad S
    Eye (Lond); 2007 Nov; 21(11):1428. PubMed ID: 17676023
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
    Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
    Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone.
    Spaide RF
    Ophthalmology; 2008 Aug; 115(8):1436; author reply 1436-7. PubMed ID: 18675704
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subtenonial application of triamcinolone in neovascular form of senile macular degeneration].
    Loncarek K; Brajac I; Stalekar H
    Acta Med Croatica; 2007 Sep; 61(4):391-3. PubMed ID: 18044474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
    Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
    Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of herpetic keratitis after intravitreal triamcinolone injection.
    Gulkilik G; Demirci G; Ozdamar AM; Muftuoglu GI
    Cornea; 2007 Sep; 26(8):1000-1. PubMed ID: 17721305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadvertent intracorneal triamcinolone injection during cataract extraction.
    Akova-Budak B; Kıvanç SA; Baykara M
    J Cataract Refract Surg; 2014 Nov; 40(11):1928-9. PubMed ID: 25442888
    [No Abstract]   [Full Text] [Related]  

  • 16. Conjunctival ischaemia subsequent to posterior subtenon's triamcinolone acetonide injection.
    Rubinstein A; Hanson RJ; Chen SD; Porter N; Downes SM
    Eye (Lond); 2006 Mar; 20(3):388-9. PubMed ID: 15803168
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathergy-like reaction following intravitreal triamcinolone acetonide injection in a patient with Behçet disease.
    Yalçindağ FN; Batioğlu F
    Ocul Immunol Inflamm; 2008; 16(4):181-3. PubMed ID: 18716954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
    Roth DB; Kulkarni KM; Walsman S; Modi A
    Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant glaucoma as a complication of intravitreal triamcinolone acetonide.
    Heatley CJ; Lim KS; Siriwardena D; Barton K
    Acta Ophthalmol Scand; 2006 Oct; 84(5):712-3. PubMed ID: 16965510
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.